Literature DB >> 24998889

Ascending aortic constriction in rats for creation of pressure overload cardiac hypertrophy model.

Ajith Kumar Gs1, Binil Raj1, Kumar S Santhosh2, G Sanjay3, Chandrasekharan Cheranellore Kartha4.   

Abstract

Ascending aortic constriction is the most common and successful surgical model for creating pressure overload induced cardiac hypertrophy and heart failure. Here, we describe a detailed surgical procedure for creating pressure overload and cardiac hypertrophy in rats by constriction of the ascending aorta using a small metallic clip. After anesthesia, the trachea is intubated by inserting a cannula through a half way incision made between two cartilage rings of trachea. Then a skin incision is made at the level of the second intercostal space on the left chest wall and muscle layers are cleared to locate the ascending portion of aorta. The ascending aorta is constricted to 50-60% of its original diameter by application of a small sized titanium clip. Following aortic constriction, the second and third ribs are approximated with prolene sutures. The tracheal cannula is removed once spontaneous breathing was re-established. The animal is allowed to recover on the heating pad by gradually lowering anesthesia. The intensity of pressure overload created by constriction of the ascending aorta is determined by recording the pressure gradient using trans-thoracic two dimensional Doppler-echocardiography. Overall this protocol is useful to study the remodeling events and contractile properties of the heart during the gradual onset and progression from compensated cardiac hypertrophy to heart failure stage.

Entities:  

Mesh:

Year:  2014        PMID: 24998889      PMCID: PMC4208884          DOI: 10.3791/50983

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

1.  Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure.

Authors:  M I Miyamoto; F del Monte; U Schmidt; T S DiSalvo; Z B Kang; T Matsui; J L Guerrero; J K Gwathmey; A Rosenzweig; R J Hajjar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 2.  Small animal models of heart failure: development of novel therapies, past and present.

Authors:  Richard D Patten; Monica R Hall-Porter
Journal:  Circ Heart Fail       Date:  2009-03       Impact factor: 8.790

3.  Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.

Authors:  H Schunkert; V J Dzau; S S Tang; A T Hirsch; C S Apstein; B H Lorell
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

4.  Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition.

Authors:  M Turcani; H Rupp
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

5.  Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure.

Authors:  Federica Del Monte; Karyn Butler; Wolfgang Boecker; Judith K Gwathmey; Roger J Hajjar
Journal:  Physiol Genomics       Date:  2002       Impact factor: 3.107

6.  Long-term angiotensin-converting enzyme inhibition with fosinopril improves depressed responsiveness to Ca2+ in myocytes from aortic-banded rats.

Authors:  Y Kagaya; R J Hajjar; J K Gwathmey; W H Barry; B H Lorell
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

7.  Lung endothelial dysfunction in congestive heart failure: role of impaired Ca2+ signaling and cytoskeletal reorganization.

Authors:  Alexander Kerem; Jun Yin; Stephanie M Kaestle; Julia Hoffmann; Axel M Schoene; Baljit Singh; Hermann Kuppe; Mathias M Borst; Wolfgang M Kuebler
Journal:  Circ Res       Date:  2010-02-18       Impact factor: 17.367

8.  Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.

Authors:  E O Weinberg; F J Schoen; D George; Y Kagaya; P S Douglas; S E Litwin; H Schunkert; C R Benedict; B H Lorell
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

Review 9.  Animal models of human cardiovascular disease, heart failure and hypertrophy.

Authors:  G Hasenfuss
Journal:  Cardiovasc Res       Date:  1998-07       Impact factor: 10.787

10.  Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.

Authors:  S E Litwin; S E Katz; E O Weinberg; B H Lorell; G P Aurigemma; P S Douglas
Journal:  Circulation       Date:  1995-05-15       Impact factor: 29.690

  10 in total
  9 in total

1.  A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats.

Authors:  Hui-Chun Ku; Shih-Yi Lee; Yuan-Kun Aden Wu; Kai-Chien Yang; Ming-Jai Su
Journal:  J Vis Exp       Date:  2016-12-02       Impact factor: 1.355

Review 2.  Surgical and physiological challenges in the development of left and right heart failure in rat models.

Authors:  Michael G Katz; Anthony S Fargnoli; Sarah M Gubara; Elena Chepurko; Charles R Bridges; Roger J Hajjar
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

Review 3.  Small mammalian animal models of heart disease.

Authors:  Paula Camacho; Huimin Fan; Zhongmin Liu; Jia-Qiang He
Journal:  Am J Cardiovasc Dis       Date:  2016-09-15

4.  AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure.

Authors:  Anca Remes; Andreas H Wagner; Markus Hecker; Oliver J Müller; Nesrin Schmiedel; Markus Heckmann; Theresa Ruf; Lin Ding; Andreas Jungmann; Frauke Senger; Hugo A Katus; Nina D Ullrich; Norbert Frey
Journal:  Basic Res Cardiol       Date:  2021-06-04       Impact factor: 17.165

5.  Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model.

Authors:  Jaime Ibarrola; Ernesto Martínez-Martínez; J Rafael Sádaba; Vanessa Arrieta; Amaia García-Peña; Virginia Álvarez; Amaya Fernández-Celis; Alicia Gainza; Patrick Rossignol; Victoria Cachofeiro Ramos; Natalia López-Andrés
Journal:  Int J Mol Sci       Date:  2017-07-31       Impact factor: 5.923

6.  Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities.

Authors:  Ping Yu Xiong; Lian Tian; Kimberly J Dunham-Snary; Kuang-Hueih Chen; Jeffrey D Mewburn; Monica Neuber-Hess; Ashley Martin; Asish Dasgupta; Francois Potus; Stephen L Archer
Journal:  Front Cardiovasc Med       Date:  2019-01-25

7.  Chronic Pressure Overload Results in Deficiency of Mitochondrial Membrane Transporter ABCB7 Which Contributes to Iron Overload, Mitochondrial Dysfunction, Metabolic Shift and Worsens Cardiac Function.

Authors:  Vikas Kumar; Aneesh Kumar A; Rahul Sanawar; Abdul Jaleel; T R Santhosh Kumar; C C Kartha
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

8.  Blockade of β-adrenergic signaling suppresses inflammasome and alleviates cardiac fibrosis.

Authors:  Shipeng Dang; Zhen-Ye Zhang; Ku-Lin Li; Jie Zheng; Ling-Ling Qian; Xiao-Yu Liu; Ying Wu; Chang-Ying Zhang; Xiao-Xi Zhao; Zhi-Ming Yu; Ru-Xing Wang; Tingbo Jiang
Journal:  Ann Transl Med       Date:  2020-02

Review 9.  Morphological and Functional Characteristics of Animal Models of Myocardial Fibrosis Induced by Pressure Overload.

Authors:  Yuejia Ding; Yuan Wang; Qiujin Jia; Xiaoling Wang; Yanmin Lu; Ao Zhang; Shichao Lv; Junping Zhang
Journal:  Int J Hypertens       Date:  2020-01-31       Impact factor: 2.420

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.